A phase II trial to determine the cosmetic outcomes and toxicity of 27 Gy in five-fraction accelerated partial breast irradiation: the ACCEL trial

被引:13
作者
Grendarova, Petra [1 ,2 ,3 ]
Quirk, Sarah [1 ,3 ,4 ]
Roumeliotis, Michael [1 ,3 ,4 ]
Lesiuk, Mark [3 ]
Austin, Tammy [3 ]
Bignell, Katelyn [3 ]
Liu, Hongwei [1 ,2 ,5 ]
Craighead, Peter [1 ,2 ,3 ]
Wilson, Jane [1 ,2 ,6 ]
Phan, Tien [1 ,2 ,3 ]
Olivotto, Ivo A. [1 ,2 ,3 ]
机构
[1] Univ Calgary, Dept Oncol, Calgary, AB, Canada
[2] Tom Baker Canc Clin, Div Radiat Oncol, 1331 29th St NW, Calgary, AB T2N 4N2, Canada
[3] Tom Baker Canc Clin, 1331 29th St NW, Calgary, AB T2N 4N2, Canada
[4] Tom Baker Canc Clin, Div Med Phys, 1331 29th St NW, Calgary, AB T2N 4N2, Canada
[5] Cent Alberta Canc Ctr, 3942 50a Ave, Red Deer, AB T4N 4E7, Canada
[6] Jack Ady Canc Ctr, 960 19 St S, Lethbridge, AB T1J 1W5, Canada
关键词
Clinical trial; Accelerated partial breast irradiation; Hypofractionation; Cosmesis; Study protocol;
D O I
10.1007/s13566-018-0359-2
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Accelerated partial breast irradiation (APBI) has been investigated in randomized controlled trials with the goals of reducing side effects and treatment burden. There is accumulating evidence that local control for multi-fraction APBI is not inferior to whole breast irradiation (WBI) but an external beam prescription that can be safely delivered in five consecutive days has not been reported. The aim of this study is to investigate an APBI prescription delivered once per day in 1 week. This is a single-arm, phase II, prospective cohort study. Two hundred seventy-four eligible women with newly diagnosed, early-stage, invasive, or in situ ductal carcinoma treated with breast-conserving surgery and sentinel lymph node biopsy or axillary dissection who are candidates for whole breast radiation without a boost will be recruited. Twenty-seven Gray (Gy) in five fractions will be delivered once daily over five consecutive working days to the target volume. The primary outcome is the rate of global cosmetic deterioration from an excellent or good score at baseline (prior to radiation therapy) to a fair or poor score at 2 years after treatment. The study is powered to demonstrate non-inferiority compared to the use of WBI arm in the RAPID trial. The ACCEL trial aims to demonstrate the safe and effective delivery of a five-fraction APBI treatment using IMRT or 3D-conformal radiation. The study is designed to account for an updated alpha/beta ratio for breast tissue and compares cosmesis to the WBI arm of the RAPID trial. The ACCEL trial was registered in February 2016 and began accrual in the subsequent May. This trial will assess the cosmetic and normal tissue outcomes of external beam APBI delivered in 1 week for early-stage breast cancer.
引用
收藏
页码:285 / 291
页数:7
相关论文
共 25 条
  • [1] Is multibeam IMRT better than standard treatment for patients with left-sided breast cancer?
    Beckham, Wayne A.
    Popescu, Carmen C.
    Patenaude, Veronica V.
    Wai, Elaine S.
    Olivotto, Ivo A.
    [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2007, 69 (03): : 918 - 924
  • [2] Bentzen SM, 2008, LANCET ONCOL, V9, P331, DOI [10.1016/S1470-2045(08)70077-9, 10.1016/S1470-2045(08)60348-7]
  • [3] Local Recurrence in Women With Stage I Breast Cancer: Declining Rates Over Time in a Large, Population-Based Cohort
    Canavan, Joycelin
    Truong, Pauline T.
    Smith, Sally L.
    Lu, Linghong
    Lesperance, Mary
    Olivotto, Ivo A.
    [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2014, 88 (01): : 80 - 86
  • [4] Partial-breast radiotherapy after breast conservation surgery for patients with early breast cancer (UK IMPORT LOW trial): 5-year results from a multicentre, randomised, controlled, phase 3, non-inferiority trial
    Coles, Charlotte E.
    Griffin, Clare L.
    Kirby, Anna M.
    Titley, Jenny
    Agrawal, Rajiv K.
    Alhasso, Abdulla
    Bhattacharya, Indrani S.
    Brunt, Adrian M.
    Ciurlionis, Laura
    Chan, Charlie
    Donovan, Ellen M.
    Emson, Marie A.
    Harnett, Adrian N.
    Haviland, Joanne S.
    Hopwood, Penelope
    Jefford, Monica L.
    Kaggwa, Ronald
    Sawyer, Elinor J.
    Syndikus, Isabel
    Tsang, Yat M.
    Wheatley, Duncan A.
    Wilcox, Maggie
    Yarnold, John R.
    Bliss, Judith M.
    [J]. LANCET, 2017, 390 (10099) : 1048 - 1060
  • [5] DEVELOPMENT AND VALIDATION OF A HEART ATLAS TO STUDY CARDIAC EXPOSURE TO RADIATION FOLLOWING TREATMENT FOR BREAST CANCER
    Feng, Mary
    Moran, Jean M.
    Koelling, Todd
    Chughtai, Aamer
    Chan, June L.
    Freedman, Laura
    Hayman, James A.
    Jagsi, Reshma
    Jolly, Shruti
    Larouere, Janice
    Soriano, Julie
    Marsh, Robin
    Pierce, Lori J.
    [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2011, 79 (01): : 10 - 18
  • [6] Prone Accelerated Partial Breast Irradiation After Breast-Conserving Surgery: Five-year Results of 100 Patients
    Formenti, Silvia C.
    Hsu, Howard
    Fenton-Kerimian, Maria
    Roses, Daniel
    Guth, Amber
    Jozsef, Gabor
    Goldberg, Judith D.
    DeWyngaert, J. Keith
    [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2012, 84 (03): : 606 - 611
  • [7] Tamoxifen with or without breast irradiation in women 50 years of age or older with early breast cancer
    Fyles, AW
    McCready, DR
    Manchul, LA
    Trudeau, ME
    Merante, P
    Pintilie, M
    Weir, LM
    Olivotto, IA
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2004, 351 (10) : 963 - 970
  • [8] The UK Standardisation of Breast Radiotherapy (START) trials of radiotherapy hypofractionation for treatment of early breast cancer: 10-year follow-up results of two randomised controlled trials
    Haviland, Joanne S.
    Owen, J. Roger
    Dewar, John A.
    Agrawal, Rajiv K.
    Barrett, Jane
    Barrett-Lee, Peter J.
    Dobbs, H. Jane
    Hopwood, Penelope
    Lawton, Pat A.
    Magee, Brian J.
    Mills, Judith
    Simmons, Sandra
    Sydenham, Mark A.
    Venables, Karen
    Bliss, Judith M.
    Yarnold, John R.
    [J]. LANCET ONCOLOGY, 2013, 14 (11) : 1086 - 1094
  • [9] Lumpectomy Plus Tamoxifen With or Without Irradiation in Women Age 70 Years or Older With Early Breast Cancer: Long-Term Follow-Up of CALGB 9343
    Hughes, Kevin S.
    Schnaper, Lauren A.
    Bellon, Jennifer R.
    Cirrincione, Constance T.
    Berry, Donald A.
    McCormick, Beryl
    Muss, Hyman B.
    Smith, Barbara L.
    Hudis, Clifford A.
    Winer, Eric P.
    Wood, William C.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (19) : 2382 - +
  • [10] Early Toxicity Results with 3-D Conformal External Beam Therapy (CEBT) from the NSABP B-39/RTOG 0413 Accelerated Partial Breast Irradiation (APBI) Trial
    Julian, T. B.
    Costantino, J. P.
    Vicini, F. A.
    White, J. R.
    Winter, K. A.
    Anhui, D. W.
    Kuske, R. R.
    Rabinovitch, R.
    Curran, W. J., Jr.
    Wolmark, N.
    [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2011, 81 (02): : S7 - S7